Literature DB >> 35947268

Successful Chemical Synovectomy in a Patient with Acquired von Willebrand Syndrome with Chronic Synovitis Due to Recurrent Knee Hemarthrosis: A Case Report.

Roberta Gualtierotti1,2, Claudio De Magistris3,4, Eugenia Biguzzi5, Jacopo Acquati Lozej5, Alessandra Iurlo4, Luigi Piero Solimeno5, Flora Peyvandi3,5.   

Abstract

Acquired von Willebrand syndrome (AVWS) is a rare, non-hereditary bleeding disorder related to heterogeneous medical conditions such as hematological malignancies and cardiovascular and autoimmune diseases. We describe the clinical course of a 62-year-old man with polycythemia vera who experienced post-traumatic knee and leg swelling due to hemarthrosis. He was treated at another center with low molecular weight heparin due to misdiagnosed deep vein thrombosis further exacerbating the ongoing bleeding. At our center, he was diagnosed with AVWS with reduced von Willebrand factor (VWF):GPIbR plasma activity and loss of high molecular weight multimers (HMWM). He was treated with compressive bandages with resolution. Five months later, on clinical recurrence of knee and leg swelling, knee ultrasound scan showed the presence of chronic synovitis and a hemorrhagic Baker's cyst with signs of rupture. The treatment consisted of chemical synovectomy with rifampicin and steroids preceded by systemic replacement therapy using plasma-derived factor VIII-VWF concentrate. At the end of the treatment cycle, our patient reported complete resolution of knee pain and restoration of joint range of motion and function. Ultrasound evaluation confirmed complete resolution of knee capsule distension and Baker's cyst. Hemarthrosis is an anecdotal presentation of AVWS and chemical synovectomy was successful in treating this complication. A multidisciplinary approach allowed an effective management of this rare complication.
© 2022. The Author(s).

Entities:  

Keywords:  Acquired von Willebrand syndrome; Chemical synovectomy; Hemarthrosis

Year:  2022        PMID: 35947268     DOI: 10.1007/s40744-022-00477-2

Source DB:  PubMed          Journal:  Rheumatol Ther        ISSN: 2198-6576


  4 in total

1.  Prevalence of acquired von Willebrand syndrome during essential thrombocythemia: a retrospective analysis of 170 consecutive patients.

Authors:  Andrzej Mital; Witold Prejzner; Maria Bieniaszewska; Andrzej Hellmann
Journal:  Pol Arch Med Wewn       Date:  2015-12-10

2.  Radioactive synovectomy with Yttrium⁹⁰ citrate in haemophilic synovitis: Brazilian experience.

Authors:  S Thomas; M B Gabriel; P E Assi; M Barboza; M L P Perri; M G P Land; E S Da Costa
Journal:  Haemophilia       Date:  2010-08-22       Impact factor: 4.287

3.  Acquired von Willebrand's syndrome during autoimmune disorder.

Authors:  J Pizzuto; R Ambriz; M de la Paz Reyna; L M Monrroy; M R Morales; A Aviles; G Conte; R Enriquez
Journal:  Thromb Haemost       Date:  1980-02-29       Impact factor: 5.249

Review 4.  Hemophilic arthropathy: Current knowledge and future perspectives.

Authors:  Roberta Gualtierotti; Luigi Piero Solimeno; Flora Peyvandi
Journal:  J Thromb Haemost       Date:  2021-07-01       Impact factor: 5.824

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.